Yue Zhou

Toyama, 9300194, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

A Curcumin Analog, 3,5-Bis(2'-ethoxybenzylidene)-piperidine-4-one (E145), Suppresses NF-κB Signaling to Inhibit Breast Cancer Growth and Metastasis.

A Curcumin Analog, 3,5-Bis(2'-ethoxybenzylidene)-piperidine-4-one (E145), Suppresses NF-κB Signaling to Inhibit Breast Cancer Growth and Metastasis.

Journal: Biological & pharmaceutical bulletin

Published: July 30, 2026

B cells promote the growth and stem-like qualities of breast cancer cells in the bone marrow.

B cells promote the growth and stem-like qualities of breast cancer cells in the bone marrow.

Journal: Biochemical and biophysical research communications

Published: June 09, 2026

Enhanced Efficacy of EGFR-Targeted ADCs via p38-Mediated Noncanonical Endocytosis in EGFR-Mutant Lung Cancer Cells.

Enhanced Efficacy of EGFR-Targeted ADCs via p38-Mediated Noncanonical Endocytosis in EGFR-Mutant Lung Cancer Cells.

Journal: Biological & pharmaceutical bulletin

Published: June 07, 2026

FGFR1 induces RSK-dependent non-canonical activation of EphA2 during EMT.

FGFR1 induces RSK-dependent non-canonical activation of EphA2 during EMT.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: March 13, 2026

DNA-Damaging Agents Induce PD-L1 Expression through the Src-STAT1-IRF1 Pathway.

DNA-Damaging Agents Induce PD-L1 Expression through the Src-STAT1-IRF1 Pathway.

Journal: Biological & pharmaceutical bulletin

Published: December 24, 2025

Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions.

Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions.

Journal: Biological & pharmaceutical bulletin

Published: July 28, 2025

Proteasome Inhibition Induces IRF1 Downstream Molecules Independently of JAK Activity in Cancers.

Proteasome Inhibition Induces IRF1 Downstream Molecules Independently of JAK Activity in Cancers.

Journal: Biological & pharmaceutical bulletin

Published: June 18, 2025

SOX10 Regulates Melanoma Metastasis Through the IRF1-ITGA3/EphA2-FAK Pathway.

SOX10 Regulates Melanoma Metastasis Through the IRF1-ITGA3/EphA2-FAK Pathway.

Journal: Cancer science

Published: June 03, 2025

The stress-activated kinase p38 mediates non-canonical activation of Src and tyrosine phosphorylation of the adapter protein TAB1.

The stress-activated kinase p38 mediates non-canonical activation of Src and tyrosine phosphorylation of the adapter protein TAB1.

Journal: The Journal of biological chemistry

Published: April 03, 2025

Stress Response Kinase MK2 Induces Non-canonical Activation of EphA2 in EML4-ALK Lung Cancer Cells.

Stress Response Kinase MK2 Induces Non-canonical Activation of EphA2 in EML4-ALK Lung Cancer Cells.

Journal: Biological & pharmaceutical bulletin

Published: March 02, 2025

Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathway.

Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathway.

Journal: Scientific reports

Published: November 22, 2024

HDAC Inhibitors Induce HLA Class I Molecules through the SOX10-IRF1 Axis in Clear Cell Sarcoma Cells.

HDAC Inhibitors Induce HLA Class I Molecules through the SOX10-IRF1 Axis in Clear Cell Sarcoma Cells.

Journal: Biological & pharmaceutical bulletin

Published: November 20, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026